Construction and Evaluation of Reconstituted High Density Lipoprotein as Effective Transfection Agent for Mesenchymal Stem Cell Based Cancer Therapy

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-B-074-Tuesday
• By: CHEN, Kerong (China Pharmaceutical University, Nanjing, China)
• Co-author(s): Kerong Chen: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  Min Li: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  Wei Wang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  
• Abstract:

  Backgrounds

  Genetically engineered mesenchymal stem cells (MSCs) as a non-viral gene delivery platform has been developed rapidly in cancer therapy owing to its excellent immunogenicity and specific tumor homing. However, high efficient and safe gene transfer into primary MSCs is preconditions to achieve antineoplastic protocols. Reconstituted..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login